CS
CRBP icon

Credit Suisse’s Corbus Pharmaceuticals CRBP Stock Holding History

Credit Suisse’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,976
Closed -$108K – 4410
2021
Q2 		$108K Buy
1,976
+1,491
+307% +$82.7K ﹤0.01% 4360
2021
Q1 		$28K Sell
485
-93
-16% -$6.11K ﹤0.01% 4250
2020
Q4 		$21K Sell
578
-23,953
-98% -$896K ﹤0.01% 4302
2020
Q3 		$1.32M Buy
24,531
+20,444
+500% +$3.7M ﹤0.01% 2728
2020
Q2 		$1.03M Buy
4,087
+1,962
+92% +$396K ﹤0.01% 2886
2020
Q1 		$334K Buy
+2,125
New +$359K ﹤0.01% 3355
2019
Q4 		– Sell
-448
Closed -$65K – 4176
2019
Q3 		$65K Sell
448
-76
-15% -$13.2K ﹤0.01% 4011
2019
Q2 		$109K Buy
524
+54
+11% +$11.6K ﹤0.01% 3941
2019
Q1 		$99K Buy
+470
New +$104K ﹤0.01% 3842
2018
Q4 		– Sell
-351
Closed -$79K – 3881
2018
Q3 		$79K Sell
351
-135
-28% -$21.8K ﹤0.01% 3726
2018
Q2 		$73K Sell
486
-363
-43% -$66K ﹤0.01% 3866
2018
Q1 		$156K Sell
849
-1,787
-68% -$401K ﹤0.01% 3736
2017
Q4 		$562K Buy
2,636
+1,670
+173% +$357K ﹤0.01% 3367
2017
Q3 		$207K Buy
+966
New +$189K ﹤0.01% 3917
2017
Q2 		– Sell
-633
Closed -$157K – 3840
2017
Q1 		$157K Buy
+633
New +$155K ﹤0.01% 3653

Other funds holding CRBP

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Credit Suisse's CRBP Position: Q3 2021 in Review

Credit Suisse sold out of Corbus Pharmaceuticals (CRBP) in Q3 2021, closing a stake of 1,976 shares — an estimated $108K sold.

Credit Suisse first reported a position in CRBP in Q1 2017 and held it in 15 quarters. The position peaked at $1.32M in Q3 2020. 85 funds tracked by Wall St. Rank hold CRBP as of Q3 2021.

  • Credit Suisse reported no remaining Corbus Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Credit Suisse sold 1,976 Corbus Pharmaceuticals shares in Q3 2021, an estimated $108K.
  • Credit Suisse first reported a position in Corbus Pharmaceuticals in Q1 2017 and held it in 15 quarters.
  • Credit Suisse's Corbus Pharmaceuticals position peaked at $1.32M in Q3 2020.
  • 85 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2021.

Based on Credit Suisse's 13F filing for Q3 2021, filed 12 Nov 2021.